Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Joshua DeVos"'
Autor:
Janet Gare, Ben Toto, Percy Pokeya, Linh-Vi Le, Nick Dala, Namarola Lote, Bangan John, Abel Yamba, Kevin Soli, Joshua DeVos, Heather Paulin, Nick Wagar, Du-Ping Zheng, Takeshi Nishijima, Peniel Boas, Angela Kelly-Hanku, Anup Gurung
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representativ
Externí odkaz:
https://doaj.org/article/ce03124f6e4a4a60af44b970fff04b48
Autor:
Joshua DeVos, Kimberly McCarthy, Victor Sewe, Grace Akinyi, Muthoni Junghae, Valarie Opollo, Janin Nouhin, Robert Shafer, Clement Zeh, Artur Ramos, Heather Alexander, Joy Chang
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT As dolutegravir (DTG)-containing HIV regimens are scaled up globally, monitoring for HIV drug resistance (HIVDR) will become increasingly important. We designed a partially multiplexed HIVDR assay using Sanger sequencing technology to monito
Externí odkaz:
https://doaj.org/article/08a0d9d70f5e44f38b42f19ef2619bd5
Autor:
Guoqing Zhang, Joshua DeVos, Sandra Medina-Moreno, Nicholas Wagar, Karidia Diallo, R Suzanne Beard, Du-Ping Zheng, Christine Mwachari, Carolyn Riwa, Boniface Jullu, Ngugi Evelyn Wangari, Mary S Kibona, Lucy W Ng'Ang'A, Elliot Raizes, Chunfu Yang
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203296 (2018)
INTRODUCTION:Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR survei
Externí odkaz:
https://doaj.org/article/01486e7b61ca4fc58e10e95bf3b404a7
Autor:
Rhea N Coler, Susan L Baldwin, Narek Shaverdian, Sylvie Bertholet, Steven J Reed, Vanitha S Raman, Xiuhua Lu, Joshua DeVos, Kathy Hancock, Jacqueline M Katz, Thomas S Vedvick, Malcolm S Duthie, Christopher H Clegg, Neal Van Hoeven, Steven G Reed
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13677 (2010)
Safe, effective adjuvants that enhance vaccine potency, including induction of neutralizing Abs against a broad range of variant strains, is an important strategy for the development of seasonal influenza vaccines which can provide optimal protection
Externí odkaz:
https://doaj.org/article/55de1dba8ffc489da4c2d89e862f4a41
Autor:
Dawit Assefa, Arimide, Minilik Demissie, Amogne, Yenew, Kebede, Taye T, Balcha, Fekadu, Adugna, Artur, Ramos, Joshua, DeVos, Clement, Zeh, Anette, Agardh, Joy, Chih-Wei Chang, Per, Björkman, Patrik, Medstrand
Publikováno v:
J Acquir Immune Defic Syndr
To determine viral load (VL) nonsuppression (VLN) rates, HIV drug resistance (HIVDR) prevalence, and associated factors among female sex workers (FSWs) in Ethiopia.A cross-sectional biobehavioral survey was conducted among FSWs in 11 cities in Ethiop
Autor:
Joy Chang, Artur Ramos, Stephanie Hackett, Mary Mogashoa, Katrina Sleeman, Sherri L. Pals, Chloe A. Teasdale, Elaine J. Abrams, Clement Zeh, Emilia D. Rivadeneira, Joshua DeVos, Anthony Muttiti
Publikováno v:
Clinical Infectious Diseases. 73:e2217-e2225
Background Children living with human immunodeficiency virus (HIV) (CLHIV) receiving antiretroviral therapy (ART) in resource-limited settings are susceptible to high rates of acquired HIV drug resistance (HIVDR), but few studies include children ini
Autor:
Frantz Jean Louis, Joshua DeVos, Sylvie Boisson, Josiane Buteau, Erin Hulland, Nathanael Segaren, Jean Wysler Domercant, Kesner François, Jacques Boncy, Barbara J. Marston, Nick Wagar, R. Suzanne Beard, Macarthur Charles, Reginald Jean-Louis, Chunfu Yang, Olbeg Désinor, Joy Chang
Publikováno v:
Pediatr Infect Dis J
The main objective of this study was to determine the frequency and patterns of HIV drug resistance-associated mutations among children under 18 months of age born to HIV-1-positive mothers enrolled in the prevention of mother-to-child transmission s
Autor:
Nick Dala, Du-Ping Zheng, Janet Gare, Percy Pokeya, Nick Wagar, Anup Gurung, Kevin Soli, Abel Yamba, Bangan John, Heather Paulin, Linh-Vi N. Le, Angela Kelly-Hanku, Ben Toto, Namarola Lote, Peniel Boas, Joshua DeVos, Takeshi Nishijima
Publikováno v:
BMC infectious diseases. 22(1)
Background Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representative survey.
Autor:
Hongxiong Guo, Lori A. Rowe, John N. Nkengasong, Kevin Tang, Kundai Moyo, Nellie Wadonda-Kabondo, Joshua DeVos, Du-Ping Zheng, Guoqing Zhang, Zhiyong Zhou, Nick Wagar, Mike Frace, Chunfu Yang, Scott Sammons
Publikováno v:
African Journal of Laboratory Medicine, Vol 7, Iss 1, Pp e1-e9 (2018)
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 7, Issue: 1, Pages: 1-9, Published: 2018
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 7, Issue: 1, Pages: 1-9, Published: 2018
Background: Minority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic failure in individuals treated with antiretroviral therapy (ART) drugs. Objective: This study aim
Autor:
Evelyn Ngugi, Guoqing Zhang, Robert Redfield, Chunfu Yang, Bernadette Ngeno, Eric J. Dziuban, Francesca Odhiambo, Emilia D. Rivadeneira, Joshua DeVos, Jennifer Sabatier, Irene Mukui, Abraham Katana, Lucy Ng’ang’a, Nick Wagar, Elliot Raizes, Karidia Diallo
Publikováno v:
The Pediatric infectious disease journal. 36(8)
A survey of 461 HIV-infected Kenyan children receiving antiretroviral therapy found 143 (31%) failing virologically. Drug resistance mutations were found in 121; 37 had L74V/I mutations, with 95% receiving abacavir (ABC)-containing regimens. L74V/I w